Study of Cases and Controls on Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Stage IIIB/IV, Non-Small Cell Lung Cancer
Both
Stage IIIB/IV, Non-Small Cell Lung Cancer
Trial Information
Study of Cases and Controls on Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.
Study of cases and controls on diagnosis and treatment strategies in patients with NSCLC
with or without EGFR mutations.
Inclusion Criteria:
- Patients with confirmed diagnosis of lung adenocarcinoma, stage IIIb/IV.
- Patients under 1st line treatment against lung adenocarcinoma.
Exclusion Criteria:
- Patients not having the information required by the protocol.
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Retrospective
Outcome Measure:
Disease free survival
Outcome Time Frame:
12 months after the diagnosis of advanced disease
Safety Issue:
No
Authority:
Argentina: Administracion Nacional de Medicamentos, Alimentos y Tecnologia Medica
Study ID:
NIS-OAR-XXX-2011/1
NCT ID:
NCT01525199
Start Date:
June 2012
Completion Date:
July 2013
Related Keywords:
- Stage IIIB/IV
- Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer,
- Epidermal Growth Factor Receptor mutation,
- Lung cancer,
- Lung adenocarcinoma
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|
